These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19947251)

  • 1. [Effects of celecoxib on the proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2].
    Xu X; Yi F; Fu X; Li D; Huang Q; Du J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Aug; 23(15):682-5. PubMed ID: 19947251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of celecoxib on invasiveness of human high-metastatic nasopharyngeal carcinoma cell line CNE-2Z].
    Luo WR; Li LX; Li SY; Jiang HG; Chen XY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Nov; 45(11):941-5. PubMed ID: 21215211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibited proliferation and expression of human nasopharyngeal carcinoma line induced by celecoxib in vitro].
    Jiang DH; Guo DY; Li HZ; Deng W
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Nov; 41(11):809-12. PubMed ID: 17283531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3].
    Xu S; Zhou WQ; Zhang ZY; Ge JP; Gao JP
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):489-93. PubMed ID: 18649743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Celecoxib induces cell cycle arrest and apoptosis in human tongue squamous carcinoma cell line Tca8113].
    Li WZ; Wang XY; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):486-9. PubMed ID: 20335116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Celecoxib enhances the lethal effects of bleomycin in human tongue squamous carcinoma cell line Tca8113].
    Li WZ; Wang XY; Li ZG; Zhang JH; Ding YQ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Mar; 44(3):140-3. PubMed ID: 19576016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on the proliferation of hepatocellular carcinoma cells].
    Tang BD; Zhou Q; Lin QH; Liu SC
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1511-3. PubMed ID: 17959527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of selective cyclooxygenase-2 inhibitor on proliferation and apoptosis of human bladder cancer cell line T24].
    Zhang J; Xu ZQ; Hu Q; Qiu XW; Wang ZR
    Ai Zheng; 2007 Apr; 26(4):377-81. PubMed ID: 17430655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE; Jeon NK; Kim J; Lee EJ
    Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Celecoxib promotes apoptosis of breast cancer cell line MDA-MB-231 through down-regulation of the NF-kappaB pathway].
    Wang L; Liu LH; Shan BE; Zhang C; Sang MX; Li J
    Ai Zheng; 2009 Jun; 28(6):569-74. PubMed ID: 19635192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells.
    Chen PY; Long QC
    Acta Pharmacol Sin; 2004 Jul; 25(7):943-9. PubMed ID: 15210070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib inhibits cellular growth, decreases Ki-67 expression and modifies apoptosis in ovarian cancer cell lines.
    Vital-Reyes V; Rodríguez-Burford C; Chhieng DC; Oelschlager DK; Reyes-Fuentes A; Barnes M; Grizzle WE
    Arch Med Res; 2006 Aug; 37(6):689-95. PubMed ID: 16824926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib enhances radiosensitivity via induction of G₂-M phase arrest and apoptosis in nasopharyngeal carcinoma.
    Zhang SX; Qiu QH; Chen WB; Liang CH; Huang B
    Cell Physiol Biochem; 2014; 33(5):1484-97. PubMed ID: 24854838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W; Yu CH; Hu KQ
    Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of celecoxib on enhancing the chemotherapic sensitivity of hydroxyurea to K562 cells and its mechanism].
    Liu DS; Zhang GS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):495-9. PubMed ID: 16137030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation.
    Yu L; Chen M; Li Z; Wen J; Fu J; Guo D; Jiang Y; Wu S; Cho CH; Liu S
    Mol Pharmacol; 2011 Mar; 79(3):608-17. PubMed ID: 21177414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines.
    Park SW; Kim HS; Hah JW; Jeong WJ; Kim KH; Sung MW
    Anticancer Drugs; 2010 Oct; 21(9):823-30. PubMed ID: 20717005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.